173 related articles for article (PubMed ID: 23906638)
81. Positive effects of ceftriaxone on pentylenetetrazol-induced convulsion model in rats.
Uyanikgil Y; Özkeşkek K; Çavuşoğlu T; Solmaz V; Tümer MK; Erbas O
Int J Neurosci; 2016; 126(1):70-5. PubMed ID: 25479320
[TBL] [Abstract][Full Text] [Related]
82. Analysis of chronic seizure onsets after intrahippocampal kainic acid injection in freely moving rats.
Bragin A; Azizyan A; Almajano J; Wilson CL; Engel J
Epilepsia; 2005 Oct; 46(10):1592-8. PubMed ID: 16190929
[TBL] [Abstract][Full Text] [Related]
83. A SNAP-25 cleaving chimera of botulinum neurotoxin /A and /E prevents TNFα-induced elevation of the activities of native TRP channels on early postnatal rat dorsal root ganglion neurons.
Nugent M; Yusef YR; Meng J; Wang J; Dolly JO
Neuropharmacology; 2018 Aug; 138():257-266. PubMed ID: 29906413
[TBL] [Abstract][Full Text] [Related]
84. Semaphorin 4D promotes inhibitory synapse formation and suppresses seizures in vivo.
Acker DWM; Wong I; Kang M; Paradis S
Epilepsia; 2018 Jun; 59(6):1257-1268. PubMed ID: 29799628
[TBL] [Abstract][Full Text] [Related]
85. Botulinum Neurotoxin Chimeras Suppress Stimulation by Capsaicin of Rat Trigeminal Sensory Neurons In Vivo and In Vitro.
Antoniazzi C; Belinskaia M; Zurawski T; Kaza SK; Dolly JO; Lawrence GW
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202143
[TBL] [Abstract][Full Text] [Related]
86. Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B.
Cheng LW; Henderson TD
Toxicon; 2011 Jul; 58(1):62-7. PubMed ID: 21600236
[TBL] [Abstract][Full Text] [Related]
87. Botulinum neurotoxin A2 reduces incidence of seizures in mouse models of temporal lobe epilepsy.
Kato K; Akaike N; Kohda T; Torii Y; Goto Y; Harakawa T; Ginnaga A; Kaji R; Kozaki S
Toxicon; 2013 Nov; 74():109-15. PubMed ID: 23954512
[TBL] [Abstract][Full Text] [Related]
88. An early decrease in cell proliferation after pentylenetetrazole-induced seizures.
Aniol VA; Stepanichev MY; Lazareva NA; Gulyaeva NV
Epilepsy Behav; 2011 Nov; 22(3):433-41. PubMed ID: 21907628
[TBL] [Abstract][Full Text] [Related]
89. Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor.
Scharfman HE; Goodman JH; Sollas AL; Croll SD
Exp Neurol; 2002 Apr; 174(2):201-14. PubMed ID: 11922662
[TBL] [Abstract][Full Text] [Related]
90. Role of TRPV1 in susceptibility to PTZ-induced seizure following repeated hyperthermia challenges in neonatal mice.
Kong WL; Min JW; Liu YL; Li JX; He XH; Peng BW
Epilepsy Behav; 2014 Feb; 31():276-80. PubMed ID: 24269027
[TBL] [Abstract][Full Text] [Related]
91. Sex differences in modulating blood brain barrier permeability by NO in pentylenetetrazol-induced epileptic seizures.
Diler AS; Uzüm G; Akgün Dar K; Aksu U; Atukeren P; Ziylan YZ
Life Sci; 2007 Mar; 80(14):1274-81. PubMed ID: 17306837
[TBL] [Abstract][Full Text] [Related]
92. Single injection of a low dose of pentylenetetrazole leads to epileptogenesis in an animal model of cortical dysplasia.
Oghlakian RO; Tilelli CQ; Hiremath GK; Alexopoulos AV; Najm IM
Epilepsia; 2009 Apr; 50(4):801-10. PubMed ID: 19396951
[TBL] [Abstract][Full Text] [Related]
93. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
[TBL] [Abstract][Full Text] [Related]
94. Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
Dong M; Tepp WH; Liu H; Johnson EA; Chapman ER
J Cell Biol; 2007 Dec; 179(7):1511-22. PubMed ID: 18158333
[TBL] [Abstract][Full Text] [Related]
95. Clinical duration of action of different botulinum toxin types in humans.
Eleopra R; Rinaldo S; Montecucco C; Rossetto O; Devigili G
Toxicon; 2020 May; 179():84-91. PubMed ID: 32184153
[TBL] [Abstract][Full Text] [Related]
96. Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.
Nakamura K; Kohda T; Shibata Y; Tsukamoto K; Arimitsu H; Hayashi M; Mukamoto M; Sasakawa N; Kozaki S
Infect Immun; 2012 Aug; 80(8):2886-93. PubMed ID: 22665374
[TBL] [Abstract][Full Text] [Related]
97. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution.
Tang-Liu DD; Aoki KR; Dolly JO; de Paiva A; Houchen TL; Chasseaud LF; Webber C
Toxicon; 2003 Oct; 42(5):461-9. PubMed ID: 14529727
[TBL] [Abstract][Full Text] [Related]
98. Convection-enhanced delivery of botulinum toxin serotype A into the nonhuman primate cisterna magna and hippocampus.
Argersinger DP; Walbridge S; Wetjen NM; Vortmeyer AO; Wu T; Butman JA; Heiss JD
J Neurosurg; 2019 Jul; 133(2):588-595. PubMed ID: 31323637
[TBL] [Abstract][Full Text] [Related]
99. The use of the dynamic weight bearing test to assess the effects of acute, intramuscularly administered botulinum neurotoxin type A1 in rats.
Cornet S; Périer C; Wagner S; Andriambeloson E; Pouzet B; Kalinichev M
Toxicon X; 2020 Sep; 7():100041. PubMed ID: 32550595
[TBL] [Abstract][Full Text] [Related]
100. Bypassing the Blood-Brain Barrier: Direct Intracranial Drug Delivery in Epilepsies.
Gernert M; Feja M
Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33255396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
